Literature DB >> 22457141

Puerarin improve insulin resistance of adipocyte through activating Cb1 binding protein path.

Ying Zhao1, You Zhou.   

Abstract

OBJECTIVE: To explore the molecular mechanism of puerarin (Pue) in improving insulin resistance through observing its effect on the insulin resistance of 3T3-Li lipocyte induced by free fatty acid (FFA).
METHODS: 3T3-L1 preadipocyte was induced by a culture solution containing insulin, isobutyo-menthyl-xanthine, and dexamethasone to mature lipocyte, and it was divided into six groups: the control group (normal cells), the model group (untreated model cells), and the four drug treatment group exposed to dimethyl biguanide (Met group), highdose puerarin (PueH group), low-dose puerarin (PueL group), and propylene glycol (PG group), respectively. Mature lipocytes in various groups, except those in the normal group, were established into insulin resistance model by FFA induction and treated respectively with corresponding drugs. Peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA expressions at the fourth, sixth, and eighth day were observed using reverse transcription polymerase chain reaction (RT-PCR); glucose transportation in various groups were observed by 2-deoxy-[(3)H]-D-glucose intake method; mRNA expression of Cb1 binding protein (CAP) was determined by RT-PCR; and glucose transporter-4 (Glut-4) transposition was detected by immune-fluorescence method.
RESULTS: PPAR-γmRNA expression increased gradually, and it showed lower levels at the fourth, sixth, and eighth day in all treatment groups than that in the model group. Glucose transportation determination showed that the transportation in the model group was 2.23±0.63, significantly lower than that in the normal group 5.05 ± 0.66 (P<0.01); as compared with the model group, they were significantly higher in the PueH and the PueL groups. In addition, the CAP mRNA expression and membranous distribution of Glut-4 were higher in the two Pue treated groups than those in the model group, respectively.
CONCLUSION: Pue could markedly improve the insulin resistance of 3T3-L1 lipocyte, which is realized possibly by way of inactivating CAP path, promoting Glut-4 transposition to cell membrane to increase the transportation of glucose.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22457141     DOI: 10.1007/s11655-012-1058-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  9 in total

1.  Fatty acid-induced insulin resistance in adipocytes.

Authors:  M Van Epps-Fung; J Williford; A Wells; R W Hardy
Journal:  Endocrinology       Date:  1997-10       Impact factor: 4.736

2.  How cells absorb glucose.

Authors:  G E Lienhard; J W Slot; D E James; M M Mueckler
Journal:  Sci Am       Date:  1992-01       Impact factor: 2.142

3.  [Effect of Ginkgo biloba extract on glucose uptake of diaphragm in diabetic rats].

Authors:  Xusheng Li; Ye Hu; Yongqiang Fu; Yanfeng Ying; Guorong Chen
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2010-02

4.  Development and comparison of two 3T3-L1 adipocyte models of insulin resistance: increased glucose flux vs glucosamine treatment.

Authors:  S A Ross; X Chen; H R Hope; S Sun; E G McMahon; K Broschat; E A Gulve
Journal:  Biochem Biophys Res Commun       Date:  2000-07-14       Impact factor: 3.575

5.  CAP defines a second signalling pathway required for insulin-stimulated glucose transport.

Authors:  C A Baumann; V Ribon; M Kanzaki; D C Thurmond; S Mora; S Shigematsu; P E Bickel; J E Pessin; A R Saltiel
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

6.  The expression of the p85alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes.

Authors:  J Rieusset; C Chambrier; K Bouzakri; E Dusserre; J Auwerx; J P Riou; M Laville; H Vidal
Journal:  Diabetologia       Date:  2001-05       Impact factor: 10.122

7.  Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction.

Authors:  H Sakoda; T Ogihara; M Anai; M Funaki; K Inukai; H Katagiri; Y Fukushima; Y Onishi; H Ono; M Fujishiro; M Kikuchi; Y Oka; T Asano
Journal:  Diabetes       Date:  2000-10       Impact factor: 9.461

8.  [Effects of rosiglitazone and metformin on insulin resistance in high-fat diet rats].

Authors:  Xiao-ping Chen; Wen-ying Yang; Shi Bu; Jian-zhong Xiao; Xue-li Liu; Na Wang; Wen-hui Zhao
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2004-04

9.  Free fatty acid-induced peripheral insulin resistance augments splanchnic glucose uptake in healthy humans.

Authors:  Mandeep Bajaj; Rachele Berria; Thongchai Pratipanawatr; Sangeeta Kashyap; Wilailak Pratipanawatr; Renata Belfort; Kenneth Cusi; Lawrence Mandarino; Ralph A DeFronzo
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-08       Impact factor: 4.310

  9 in total
  5 in total

1.  Jia-Wei-Jiao-Tai-Wan ameliorates type 2 diabetes by improving β cell function and reducing insulin resistance in diabetic rats.

Authors:  Guang Chen; Xueping Yang; Xiaoyu Yang; Lingli Li; Jinlong Luo; Hui Dong; Lijun Xu; Ping Yi; Kaifu Wang; Xin Zou; Fuer Lu
Journal:  BMC Complement Altern Med       Date:  2017-11-29       Impact factor: 3.659

2.  Puerarin promotes osteogenesis and inhibits adipogenesis in vitro.

Authors:  Nan Wang; Xinluan Wang; Wenxiang Cheng; Huijuan Cao; Peng Zhang; Ling Qin
Journal:  Chin Med       Date:  2013-08-21       Impact factor: 5.455

3.  Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway.

Authors:  Jian Luo; Jian Qu; Rui Yang; Meng-Xue Ge; Yin Mei; Bo-Ting Zhou; Qiang Qu
Journal:  Front Pharmacol       Date:  2016-06-29       Impact factor: 5.810

4.  Radix Puerariae and Fructus Crataegi mixture inhibits renal injury in type 2 diabetes via decreasing of AKT/PI3K.

Authors:  Zhengyue Chen; Yanyan Yuan; Xinrong Zou; Mengqi Hong; Ming Zhao; Yu Zhao; Yuanping Liu; Guofu Li; Yabin Zhu; Lin Luo; Beiyan Bao; Shizhong Bu
Journal:  BMC Complement Altern Med       Date:  2017-09-08       Impact factor: 3.659

Review 5.  Molecular Mechanism of Puerarin Against Diabetes and its Complications.

Authors:  Yi-Ling Bai; Ling-Ling Han; Jun-Hui Qian; Hao-Zhong Wang
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.